Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Carboplatin/gemcitabine/pembrolizumab

Transverse myelitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Vertes A, et al. MRI Negative Transverse Myelitis Following Chemotherapy and Immunotherapy: A Case Report. P M and R - The Journal of Injury, Function and Rehabilitation 14 (Spec. issue 1): S35-S36, Oct 2022. Available from: URL: http://doi.org/10.1002/pmrj.12913 [abstract] Vertes A, et al. MRI Negative Transverse Myelitis Following Chemotherapy and Immunotherapy: A Case Report. P M and R - The Journal of Injury, Function and Rehabilitation 14 (Spec. issue 1): S35-S36, Oct 2022. Available from: URL: http://​doi.​org/​10.​1002/​pmrj.​12913 [abstract]
Metadaten
Titel
Carboplatin/gemcitabine/pembrolizumab
Transverse myelitis: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30506-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Tozinameran

Case report

Doxorubicin

Case report

Warfarin